Anson Funds Management’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
Sell
-81,990
Closed -$243K 28
2018
Q4
$243K Buy
+81,990
New +$243K 0.14% 31